Novartis Reports - Industry Research

Europe Over-the-counter (OTC) Drugs Market

The European over-the-counter (OTC) drugs market was valued at USD 35,258 million in 2021 and is expected to reach USD 48,377 million in 2027, registering a CAGR of 5.4% during the forecast period (2022-2027).

Drug Discovery Market

The Drug Discovery Market size is estimated at USD 100.10 billion in 2024, and is expected to reach USD 137.72 billion by 2029, growing at a CAGR of 6.59% during the forecast period (2024-2029).

Global Biosimilars Market

The Global Biosimilars Market size is estimated at USD 35.47 billion in 2024, and is expected to reach USD 82.27 billion by 2029, growing at a CAGR of 18.32% during the forecast period (2024-2029).

Global Pancreatic Cancer Therapeutics and Diagnostics Market

The Global Pancreatic Cancer Therapeutics and Diagnostics Market size is estimated at USD 4.56 billion in 2024, and is expected to reach USD 6.55 billion by 2029, growing at a CAGR of 7.52% during the forecast period (2024-2029).

Precision Medicine Market

The Precision Medicine Market size is estimated at USD 81.03 billion in 2024, and is expected to reach USD 104.40 billion by 2029, growing at a CAGR of 5.20% during the forecast period (2024-2029).

Ulcerative Colitis Market

The ulcerative colitis market size is expected to grow from USD 7.49 billion in 2023 to USD 9.00 billion by 2028, registering a CAGR of 3.75% during the forecast period.

Recombinant Protein Market

The Recombinant Protein Market size is estimated at USD 2.69 billion in 2024, and is expected to reach USD 3.94 billion by 2029, growing at a CAGR of 7.91% during the forecast period (2024-2029).

Cardiovascular Drugs Market

The cardiovascular drugs market is expected to witness growth significantly at a CAGR of 3.8% during the forecast period.

Drug Device Combination Products Market

The Drug Device Combination Products Market size is estimated at USD 132.99 billion in 2024, and is expected to reach USD 176.29 billion by 2029, growing at a CAGR of 5.80% during the forecast period (2024-2029).

Transdermal Skin Patches Market

The Transdermal Skin Patches Market size is estimated at USD 8.92 billion in 2024, and is expected to reach USD 11.33 billion by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).

Canada Pharmaceutical Market

The Canada Pharmaceutical Market size is estimated at USD 33.34 billion in 2024, and is expected to reach USD 41.94 billion by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).

Generic Drugs Market

The Generic Drugs Market size is estimated at USD 413.60 billion in 2024, and is expected to reach USD 508.79 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).

Acute Myeloid Leukemia Market

The Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 10.15% during the forecast period (2024-2029).

Global Ophthalmic Drugs Market

The Global Ophthalmic Drugs Market size is estimated at USD 52.99 billion in 2024, and is expected to reach USD 78.73 billion by 2029, growing at a CAGR of 8.24% during the forecast period (2024-2029).

Global Orphan Drugs Market

The Global Orphan Drugs Market size is estimated at USD 217.35 billion in 2024, and is expected to reach USD 294.17 billion by 2029, growing at a CAGR of 6.24% during the forecast period (2024-2029).

Global Hormone Replacement Therapy Market

The hormone replacement therapy market with a CAGR of 7.59% during the forecast period (2022-2027).

Neurodegenerative Disease Market

The Neurodegenerative Disease Market size is estimated at USD 55.12 billion in 2024, and is expected to reach USD 77.82 billion by 2029, growing at a CAGR of 7.14% during the forecast period (2024-2029).

Global Nuclear Medicine Market

The Nuclear Medicine Market is expected to grow significantly at a CAGR of 9.5% during the study period, 2022-2027.

Global Psoriasis Drugs Market

The psoriasis drugs market is expected to register a CAGR of 9.89% during the forecast period, 2022-2027.

North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The North America Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 4.02 billion in 2024, and is expected to reach USD 4.20 billion by 2029, growing at a CAGR of 0.9% during the forecast period (2024-2029).

Middle East And Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Middle East And Africa Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 758.32 million in 2024, and is expected to reach USD 893.21 million by 2029, growing at a CAGR of 3.60% during the forecast period (2024-2029).

Meglitinide Market

The Meglitinide Market size is estimated at USD 4.35 billion in 2024, and is expected to reach USD 4.85 billion by 2029, growing at a CAGR of 2.21% during the forecast period (2024-2029).

Epilepsy Drugs Market

The epilepsy drugs market is projected to register a CAGR of 3.5% during the forecast period.

Macular Degeneration Treatment Market

The Macular Degeneration Treatment Market size is estimated at USD 15.47 billion in 2024, and is expected to reach USD 23.29 billion by 2029, growing at a CAGR of 8.51% during the forecast period (2024-2029).

Pediatric Healthcare Market

The pediatric healthcare market is anticipated to register a CAGR of 6.35% during the forecast period.

Global Monoclonal Antibodies Market

The monoclonal antibodies market is expected to register a CAGR of 8.51% during the forecast period (2022-2027).

Omeprazole and Antihistamine Market

The omeprazole and antihistamine market is expected to register a CAGR of 5.7% over the forecast period.

Alprazolam Powder Market

The alprazolam powder market is expected to register a CAGR of 5.3% over the forecast period.

Brazil Oral Anti-Diabetic Drug Market

The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 13 billion in the current year.

Neurological Disorder Drugs Market

The Neurological Disorder Drugs Market is expected to register a CAGR of 5.6% during the forecast period.

Antihistamine Market

The antihistamine market is expected to register a CAGR of 7.7% over the forecast period.

Europe Monoclonal Antibodies Market

The Europe monoclonal antibodies market is expected to register a CAGR of 9.4% over the forecast period.

Hepatitis C Market

The hepatitis C market is poised to register a CAGR of 12.82% over the forecast period.

Antibiotic Resistance Market

The antibiotic resistance market was valued at USD 8.5 billion in the base year and is expected to be valued at USD 10.5 billion, registering a CAGR of 5.4 over the forecast period.

Contact Lens Market

The global contact lens market is projected to register a CAGR of 5.92% during the forecast period, 2020 to 2025.

Lung Cancer Therapeutics Market

The lung cancer therapeutics market is projected to register a CAGR of 8.7% during the forecast period.

Dermatological Therapeutics Market

The Dermatological Therapeutics Market size is estimated at USD 45.17 billion in 2024, and is expected to reach USD 71.66 billion by 2029, growing at a CAGR of 9.67% during the forecast period (2024-2029).

Breast Cancer Therapy Market

The breast cancer therapy market is expected to record a CAGR of 8.3% over the forecast period.

Bone Cancer Treatment Market

The Bone Cancer Treatment Market size is estimated at USD 1.22 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 5.27% during the forecast period (2024-2029).

Asthma and COPD Drugs Market

Asthma and COPD drugs market is expected to witness a CAGR of 4.6% during the forecast period.

Immunotherapy Drugs Market

The Immunotherapy Drugs Market size is estimated at USD 118 billion in 2024, and is expected to reach USD 192 billion by 2029, growing at a CAGR of 8.40% during the forecast period (2024-2029).

Global Polycystic Ovarian Syndrome Treatment Market

The polycystic ovarian syndrome (PCOS) treatment market is expected to register a growth rate of 5.2% over the forecast period., 2022-2027.

Anti Inflammatory Drugs Market

Anti-inflammatory drugs are the drugs that are used to treat conditions like Asthma, Arthritis, Chronic obstructive pulmonary disease (COPD) and other diseases.

Gene Therapy Market

The Gene Therapy Market size is estimated at USD 7.18 billion in 2024, and is expected to reach USD 24.67 billion by 2029, growing at a CAGR of 28% during the forecast period (2024-2029).

Glaucoma Treatment Market

The major factors for the growth of the glaucoma treatment market include the increasing prevalence of glaucoma, rising initiatives to increase awareness about glaucoma, and technological advancements in the field of ophthalmology. 

Ear Infection Treatment Market

The Ear Infection Treatment Market size is estimated at USD 12.23 billion in 2024, and is expected to reach USD 15.09 billion by 2029, growing at a CAGR of 4.29% during the forecast period (2024-2029).

Tyrosine Kinase Inhibitors Market

The Tyrosine Kinase Inhibitors Market size is estimated at USD 62.13 billion in 2024, and is expected to reach USD 92.86 billion by 2029, growing at a CAGR of 8.37% during the forecast period (2024-2029).

Thalassemia Treatment Market

The thalassemia treatment market studied was projected to grow with a CAGR of nearly 7.6% over the forecast period.

Chronic Lymphocytic Leukemia Market

The Chronic Lymphocytic Leukemia (CLL) Market is expected to register a CAGR of 6.01% over the forecast period.

Neuropathic Pain Market

The neuropathic pain market studied is anticipated to register a CAGR of 5.5% during the forecast period.

Systemic Lupus Erythematosus Market

The systemic lupus erythematosus market is poised to grow at a CAGR of 7.1% during the forecast period.

Dysmenorrhea Treatment Market

The dysmenorrhea treatment market is expected to register a CAGR of 8.1% during the forecast period.

Global Acromegaly Treatment Market

The Acromegaly Treatment Market is expected to register a CAGR of 7.4% during the forecast period, 2022-2027.

Global Corticosteroids Market

The corticosteroid market is expected to witness a CAGR of 4.3% during the forecast period (2022-2027).

Netherlands Pharmaceutical Market

The Dutch pharmaceutical market is anticipated to show moderate growth with a CAGR of 5.8% during the forecast period.

Sweden Pharmaceutical Market

The Sweden Pharmaceutical market is anticipated to register a CAGR of 3.9% over the forecast period (2022-2027).

Global Oncology Clinical Trials Market

The global oncology clinical trials market is expected to witness a CAGR of 5.4% during the forecast period (2022-2027).

Global Bronchodilators Market

The bronchodilators market studied is expected to grow with an estimated CAGR of 4.7%, over the forecast period.

Global Advanced Therapy Medicinal Products (ATMPs) Market

The advanced therapy medicinal products (ATMPs) market is projected to register a CAGR of 13% during the forecast period.

Global Transplantation Market

The Transplantation Market is expected to register a CAGR of 9.9% during the forecast period (2022-2027).

Nucleic Acid Based Therapeutics Market

The Nucleic Acid Based Therapeutics Market size is estimated at USD 5.59 billion in 2024, and is expected to reach USD 10.90 billion by 2029, growing at a CAGR of 14.29% during the forecast period (2024-2029).

Global T-Cell Lymphoma Market

The Global T-Cell Lymphoma Market size is estimated at USD 2.21 billion in 2024, and is expected to reach USD 3.05 billion by 2029, growing at a CAGR of 6.66% during the forecast period (2024-2029).

Global Nasopharyngeal Cancer Market

Over the next few years, the market for nasopharyngeal cancer is expected to grow at a CAGR of 2.7%.

Europe Nuclear Medicine Market

The Europe Nuclear Medicine Market is expected to register a CAGR of 10% during the forecast period.

Brazil Drug Delivery Devices Market

The Brazil drug delivery devices market is expected to register a CAGR of 4.5% over the forecast period.

North America Over the Counter Drugs Market

The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period.

Global Leukemia Therapeutics Market

The Leukemia Therapeutics Market is expected to register a CAGR of 5.5% over the forecast period.

Global Topical Drug Delivery Market

The Topical Drug Delivery Market is expected to witness a CAGR of 8.5% during the forecast period (2022 - 2027).

Global Cytokine Market

The cytokine market is expected to register a CAGR of 6.2% during the forecast period (2022-2027).

North America Kidney Cancer Therapeutics & Diagnostics Market

The North America Kidney Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 5.8% during the forecast period.

Global Melanoma Diagnostics and Therapeutics Market

The Melanoma Diagnostics and Therapeutics market is expected to register a CAGR of 15.1% over the forecast period, 2022-2027.

Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Europe Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 1.79 billion in 2024, and is expected to reach USD 2.04 billion by 2029, growing at a CAGR of 2.73% during the forecast period (2024-2029).

Global Cancer Supportive Care Drugs Market

The cancer supportive care drugs market is expected to register a CAGR of nearly 3.56% during the forecast period (2022-2027).

Anti-infective Drugs Market

The anti-infective drugs market is expected to witness a CAGR of 3.5% over the forecast period.

Meningococcal Vaccines Market

The meningococcal vaccines market is expected to register a CAGR of around 9.5% over the forecast period.

Global Anti Malarial Drugs Market

The Anti Malarial Drugs market is expected to register a CAGR of 3.7% over the forecast period (2022-2027).

Global Artemisinin Combination Therapy Market

Over the next few years, the market for artemisinin combination therapy is expected to grow at a CAGR of 8.31%.

Multiple Sclerosis Therapeutics Market

The Multiple Sclerosis Therapeutics Market size is estimated at USD 29.65 billion in 2024, and is expected to reach USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029).

Global Neuroendocrine Tumor Treatment Market

The Neuroendocrine Tumor Treatment Market is projected to register a CAGR of 10% during the forecast period (2022 - 2027).

Liver Diseases Therapeutics Market

During the forecast period, the market for medicines to treat liver disease is expected to register a CAGR of about 8.5%.

Sarcopenia Treatment Market

The Sarcopenia Treatment Market size is estimated at USD 3.07 billion in 2024, and is expected to reach USD 4.02 billion by 2029, growing at a CAGR of 4.48% during the forecast period (2024-2029).

Conjunctivitis Treatment Market

The conjunctivitis treatment market is expected to register a CAGR of 4.1% over the forecast period.

Allergy Relieving Eye Drops Market

The allergy-relieving eye drops market is expected to register a CAGR of 4.14% during the forecast period.

Gram-positive Bacterial Infections Market

The gram-positive bacterial infections market is expected to register a CAGR of 8.0% over the forecast period.

Global Digital Dose Inhaler Market

The digital dose inhaler market is anticipated to grow with a CAGR of above 13.3% during the forecast period.

Global Hypertrophic Cardiomyopathy Therapeutics Market

The Hypertrophic Cardiomyopathy Therapeutics Market is expected to grow at a CAGR of 1.8% over the forecast period (2022-2027).

Global T-cell Acute Lymphoblastic Leukemia Treatment Market

The T-cell Acute Lymphoblastic Leukemia Treatment Market is anticipated to grow with a CAGR of nearly 7.8% over the forecast period.

CINV Treatment Market

The CINV treatment market studied was projected to grow with a CAGR of nearly 5.8% over the forecast period.

Chronic Myelogenous Leukemia Treatment Market

The chronic myelogenous leukemia (CML) treatment market is expected to register a CAGR of 5.3% over the forecast period.

Global Cell Based Immunotherapy Market

The cell-based immunotherapy market is expected to register a CAGR of 15.5% during the forecast period.

Autologous Stem Cell and Non-Stem Cell Based Therapies Market

The autologous stem cell and non-stem cell-based therapies market is anticipated to register a CAGR of 14.26% over the forecast period.

Menopausal Hot Flashes Market

The menopausal hot flashes market is projected to register a CAGR of 3.4% during the forecast period.

Global Narcolepsy Therapeutics Market

The narcolepsy therapeutics market is anticipated to witness a CAGR of 9.9% during the forecast period (2022-2027).

Global Cardiac Arrest Treatment Market

The cardiac arrest treatment market is expected to register a CAGR of 4.8% over the forecast period.

Global Myeloproliferative Disorders (MPD) Treatment Market

The myeloproliferative disorders (MPD) treatment market is expected to register a CAGR of 4.9% over the forecast period.

Coronary Artery Disease Therapeutics Market

The Coronary Artery Disease Therapeutics Market is expected to register a CAGR of 7.7% during the forecast period.

Global Onychomycosis Treatment Market

The Global Onychomycosis Treatment Market size is estimated at USD 3.36 billion in 2024, and is expected to reach USD 4.18 billion by 2029, growing at a CAGR of 4.46% during the forecast period (2024-2029).

Optic Neuritis Treatment Market

The optic neuritis treatment market is expected to register a CAGR of 4.1% over the forecast period.

Cyclosporine Drugs Market

The cyclosporine drugs market is expected to register a CAGR of 4.1% over the forecast period.

Global Gene Delivery Systems Market

The gene delivery systems market is anticipated to register a CAGR of 7.3% over the forecast period.

Imatinib Drug Market

The Imatinib Drug Market is expected to register a CAGR of 3% during the forecast period.

Infertility Drugs Market

The infertility drugs market is expected to register a CAGR of 6.5% over the forecast period.

Global Spinal Muscular Atrophy Treatment Market

The spinal muscular atrophy treatment market is expected to register a CAGR of 14.5% during the forecast period.

Subdermal Contraceptive Implants Market

The subdermal contraceptive implants market is expected to register a CAGR of 3.5% over the forecast period.

Iceland Pharmaceutical Market

The Iceland Pharmaceutical market studied was anticipated to show a low growth with a CAGR of 2.8%, during the forecast period (2022-2027).

Central Nervous System Therapeutics Market

The Global Central Nervous System Therapeutics Market size is expected to grow from USD 112,884.87 million in 2023 to USD 151,208.00 million by 2028, at a CAGR of 6.02% during the forecast period.

Sickle Cell Treatment Market

The Sickle Cell Treatment Market size is estimated at USD 3.32 billion in 2024, and is expected to reach USD 6.11 billion by 2029, growing at a CAGR of 12.98% during the forecast period (2024-2029).

Penicillin Drug Market

The Penicillin Drug Market size is estimated at USD 10.71 billion in 2024, and is expected to reach USD 12.55 billion by 2029, growing at a CAGR of 3.21% during the forecast period (2024-2029).

Non-Small Cell Lung Cancer (NSCLC) Market

The non-small cell lung cancer (NSCLC) market is expected to register a CAGR of 9.5% during the forecast period.

Global Specialty Injectable Generics Market

The specialty injectable generic market is projected to register a CAGR of 10.2% during the forecast period (2022-2027).

Central Nervous System (CNS) Stimulant Drugs Market

The central nervous system (CNS) stimulant drugs market is expected to register a CAGR of 5.5% over the forecast period.

Global Antisense and RNAi Therapeutics Market

The antisense and RNAi therapeutics market is expected to register a CAGR of 7.1% over the forecast period, 2022-2027.

Lactobionic Acid Market

The lactobionic acid market is projected to register a CAGR of 5.2% over the forecasted period.

Acute Lymphoblastic Leukemia Therapeutics Market

One of the major factors responsible for the growth of this market includes the rising occurrence of acute lymphoblastic leukemia (ALL) globally.

Japan Drug Delivery Devices Market

The Japan Drug Delivery Devices Market is expected to register a CAGR of nearly 4.5% during the forecast period.

United States Drug Delivery Devices Market

The US drug delivery devices market is expected to register a CAGR of 22.78% during the forecast period.

Australia Drug Delivery Devices Market

The Australian drug delivery device market is expected to register a CAGR of nearly 5.1% during the forecast period.

Global Cancer Monoclonal Antibodies Market

The cancer monoclonal antibodies market is expected to witness a CAGR of 9.2% during the forecast period (2022-2027).

Brain Tumor Therapeutics Market

The brain tumor therapeutics market is valued at USD 2.70 billion and is expected to reach to USD 4.5 billion registering a CAGR of 11.0% during the forecast period.

United Kingdom Drug Delivery Devices Market

• The United Kingdom's drug delivery devices market is anticipated to register a CAGR of 22.81% during the forecast period.

Sarcoma Drugs Market

The sarcoma drugs market is expected to register a CAGR of 8.2% over the forecast period.

Global Anterior Uveitis Treatment Market

Over the next few years, the market for treatments for anterior uveitis is expected to grow at a CAGR of 5.8%.

Pediatric Respiratory Disease Therapeutics Market

The pediatric respiratory disease therapeutics market is expected to register a CAGR of 5.6% over the forecast period.

Global Immunosuppressant Drugs Market

The immunosuppressant drugs market is expected to register a CAGR of 4.6% during the forecast period.

Proliferative Diabetic Retinopathy Market

The Proliferative Diabetic Retinopathy Market is expected to register a CAGR of 9.4% during the forecast period.

Calcium Channel Blocker Market

The Calcium Channel Blocker Market is expected to register a CAGR of 5.1% during the forecast period.

Meperidine Drugs Market

The global meperidine drugs market size is expected to grow at a CAGR of 4.1% over the forecast period.

Osteonecrosis Treatment Market

The osteonecrosis treatment market is expected to register a CAGR of 6.2% during the forecast period.

Inhalation and Nasal Spray Generic Drugs Market

The inhalation and nasal spray generic drugs market is anticipated to register a CAGR of nearly 5.4% during the forecast period.

Sustained Release Excipients Market

The sustained release excipients market is anticipated to register a CAGR of 7.1% during the forecast period.

Infectious Enteritis Treatment Market

The Infectious Enteritis Treatment market is anticipated to grow with a CAGR of nearly 4.9% during the forecast period.

Pulmonary Drug Delivery Systems Market

The pulmonary drug delivery systems market is expected to register a CAGR of 4% during the forecast period.

Global Ethical Pharmaceuticals Market

The Ethical Pharmaceuticals Market is expected to register a CAGR of 10.5% during the forecast period (2022-2027).

Global CAR T-Cell Therapy Market

The CAR T-cell therapy market is expected to register a CAGR of more than 30% over the forecast period.

Prostate Health Market

The prostate health market is expected to register a CAGR of 9.1% over the forecast period.

Leptospirosis Market

The leptospirosis market is projected to register a CAGR of 6.1% during the forecast period.

Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market

The market studied is majorly driven by the factors such as the increasing prevalence of pancreatic cancer, increasing demand for diagnostic tests and treatment of this disease.

South America America Pancreatic Cancer Therapeutics and Diagnostics Market

The market studied is majorly driven by factors, such as the increasing prevalence of pancreatic cancer and the increasing demand for diagnostic tests and treatments of this disease.

France Drug Delivery Devices Market

The French drug delivery devices market is anticipated to expand at a CAGR of 5.2% over the forecast period.

Retinoblastoma Treatment Market

The Retinoblastoma Treatment Market size is estimated at USD 1.85 billion in 2024, and is expected to reach USD 2.30 billion by 2029, growing at a CAGR of 4.45% during the forecast period (2024-2029).

Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market

The Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 4.1% during the forecast period.

South America Kidney Cancer Therapeutics & Diagnostics Market

Kidney cancer is a disease that starts in the kidneys.

Latin America Melanoma Diagnostics and Therapeutics Market

The Latin America Melanoma Diagnostics and Therapeutics Market is expected to register a CAGR of 13.8% over the forecast period.

Germany Drug Delivery Devices Market

The Germany Drug Delivery Devices market is expected to register a 7.6% CAGR during the forecast period.

Global Cervical Cancer Diagnostics and Therapeutics Market

The Global Cervical Cancer Diagnostics and Therapeutics Market size is expected to grow from USD 95.69 billion in 2023 to USD 124.74 billion by 2028, at a CAGR of 5.44% during the forecast period (2023-2028).

Europe Novel Drug Delivery System (NDDS) Market

European novel drug delivery system market primarily driven by technological advancements promoting the development of NDDS and the rising need for controlled release of drugs.

Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Asia-Pacific Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 4.30 billion in 2024, and is expected to reach USD 5.18 billion by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).

Global Urothelial Cancer Drugs Market

The urothelial cancer drugs market studied is projected to register a CAGR of 15.5% over the forecast period.

Asia-Pacific Acute Myeloid Leukemia Treatment Market

The Asia-Pacific Acute Myeloid Leukemia Treatment Market size is estimated at USD 338.96 million in 2024, and is expected to reach USD 517.24 million by 2029, growing at a CAGR of 6.46% during the forecast period (2024-2029).

Lipid Disorder Treatment Market

The major factors attributing to the growth of the lipid disorder treatment market are the growing prevalence of lifestyle diseases like obesity and increasing smoking and alcohol consumption.

Organ Transplant Immunosuppressant Drugs Market

The organ transplant immunosuppressant drugs market is expected to register a CAGR of 3.5% during the forecast period.

Global HER-2 Negative Breast Cancer Market

The Global HER-2 Negative Breast Cancer Market size is estimated at USD 15.03 billion in 2024, and is expected to reach USD 23.32 billion by 2029, growing at a CAGR of 9.17% during the forecast period (2024-2029).

Peripheral Neuritis Treatment Market

The peripheral neuritis treatment market is expected to register a CAGR of 3.3% during the forecast period.

Wave-front Aberrometer Market

The wave-front aberrometer market is expected toregister a CAGR of XX% over the forecast period, due to the growing burden of eye diseases and technological advancements in the devices.

Triamcinolone Ointment Chlorofluorocarbons Market

Skin disease is one of the leading causes of the increasing global disease burden, affecting millions of people worldwide.

Incretin-based Drugs Market

The incretin-based drugs market is expected to register a CAGR of 5.2% during the forecast period.

Global Interleukin Inhibitors Market

The Interleukin Inhibitors Market is expected to register a CAGR of 12.5% during the forecast period.

Oral Transmucosal Drugs Market

The oral transmucosal drugs market is expected to grow at a CAGR of 7.4% over the forecast period.

Ankylosing Spondylitis Treatment

The Ankylosing Spondylitis Treatment Market size is estimated at USD 6.64 billion in 2024, and is expected to reach USD 9.72 billion by 2029, growing at a CAGR of 7.75% during the forecast period (2024-2029).

Global Neuroprotective Agents Market

The Neuroprotective Agents Market is projected to register a CAGR of 6.70% during the forecast period (2022-2027).

Global Hypersomnia Treatment Market

The Hypersomnia Treatment market is projected to register a CAGR of 8.7% during the forecast period (2022 - 2027).

Global Neurology Clinical Trials Market

The neurology clinical trials market is expected to register a CAGR of 4.35% during the forecast period (2022-2027).

Global Axial Spondyloarthritis (axSpA) Market

The Axial Spondyloarthritis market is projected to register a CAGR of 7.37% during the forecast period (2022-2027).

Global Antiparasitic Drugs Market

The antiparasitic drugs market is projected to grow with a CAGR of 5.1% during the forecast period (2022 - 2027).

Global Acute Otitis Media Treatment Market

The acute otitis media treatment market is expected to register a CAGR of 5.5% during the forecast period, 2022-2027.

Chemotherapy-Induced Neutropenia (CIN) Treatment Market

The chemotherapy-induced neutropenia (CIN) treatment size is estimated at USD XX million in 2023.

Global Metastatic Cancer Treatment Market

The metastatic cancer treatment market is expected to register a CAGR of 8.1% over the forecast period, 2022-2027.

Endocrinology Drugs Market

The endocrinology drugs market is expected to register a CAGR of 6.8% over the forecast period.

Global Metastatic Melanoma Drugs Market

The metastatic melanoma drugs market is expected to register a CAGR of 9.7% over the forecast period, 2022-2027.

Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Latin America Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 754.60 million in 2024, and is expected to reach USD 931.40 million by 2029, growing at a CAGR of 4.30% during the forecast period (2024-2029).

Latin America Meglitinide Market

The Latin America Meglitinide Market size is estimated at USD 0.22 billion in current year, and is expected to reach USD 0.26 million by forecast year, growing at a CAGR of 3.30% during the forecast period.

Europe Meglitinide Market

The Europe Meglitinide Market size is estimated at USD 1.08 billion in current year, and is expected to reach USD 1.21 billion by forecast year, growing at a CAGR of 2.30% during the forecast period.

North America Meglitinide Market

The North America Meglitinide Market size is expected to grow from USD 0.98 billion in current year to USD 1.05 billion by forecat year, at a CAGR of 1.50% during the forecast period.

APAC Meglitinide Market

The Asia-Pacific Meglitinide Market size is estimated at USD 1.62 billion in current year, and is expected to reach USD 1.76 billion by forecat year, growing at a CAGR of 1.70% during the forecast period.

Middle East And Africa Meglitinide Market

The Middle-East and Africa Meglitinide Market size is estimated at USD 0.2 billion in current year, and is expected to reach USD 0.3 billion by forecast year, growing at a CAGR of 4% during the forecast period.

Thyroid Eye Disease Treatment Market

According to the NCBI, thyroid eye disease is a complex inflammatory disorder of the eye orbit, which includes the orbital fibroblasts, adipocytes, extra-ocular muscles, optic nerve, and orbital vasculature.

United States Active Pharmaceutical Ingredients (API) Market

The United States Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 9.5% over the forecast period.

United Kingdom Active Pharmaceutical Ingredients (API) Market

The United Kingdom Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6.3% over the forecast period.

Germany Active Pharmaceutical Ingredients (API) Market

The German Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6% over the forecast period.

France Active Pharmaceutical Ingredients (API) Market

The French Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 6.1% over the forecast period.

Saudi Arabia Active Pharmaceutical Ingredients (API) Market

The Saudi Arabian Active Pharmaceutical Ingredients (API) market is expected to register a CAGR of 2% over the forecast period.

Next-Generation Immunology Drugs Market

The Next-Generation Immunology Drugs Market is expected to register a CAGR of 6.1% over the forecast period.